NEOADJUVANT
Clinical trials for NEOADJUVANT explained in plain language.
Never miss a new study
Get alerted when new NEOADJUVANT trials appear
Sign up with your email to follow new studies for NEOADJUVANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to stop kidney Cancer's return
Disease control Recruiting nowThis study is testing if giving two cancer drugs before surgery helps keep kidney cancer from coming back. It will compare patients who get the drug combination plus surgery to those who get surgery alone. The goal is to see if this approach helps patients live longer without the…
Matched conditions: NEOADJUVANT
Phase: PHASE3 • Sponsor: ZHOU FANGJIAN • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New targeted attack on advanced ovarian cancer shows promise
Disease control Recruiting nowThis study is testing whether a new targeted drug called mirvetuximab soravtansine, when combined with standard chemotherapy (carboplatin), can shrink tumors before surgery in people with advanced ovarian, fallopian tube, or primary peritoneal cancer. The treatment is designed to…
Matched conditions: NEOADJUVANT
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New hope for esophageal cancer patients: trial tests powerful Pre-Surgery combo
Disease control Recruiting nowThis study is testing a new combination of drugs given before surgery for people with a type of esophageal cancer that can be surgically removed but is locally advanced. The goal is to see if adding a newer immunotherapy drug (AK112) to standard chemotherapy drugs helps shrink th…
Matched conditions: NEOADJUVANT
Phase: PHASE1, PHASE2 • Sponsor: Tang-Du Hospital • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC